Dacogen (Eisai Inc.)
Welcome to the PulseAid listing for the Dacogen drug offered from Eisai Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Eisai Inc. |
| NON-PROPRIETARY NAME: | decitabine |
| SUBSTANCE NAME: | DECITABINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1996-05-03 |
| END MARKETING DATE: | 2018-12-31 |
Dacogen HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dacogen from Eisai Inc. |
| LABELER NAME: | Eisai Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/20mL) |
| START MARKETING DATE: | 1996-05-03 |
| END MARKETING DATE: | 2018-12-31 |
| PRODUCT ID: | 62856-600_6c0cc062-642e-447b-a269-bc8e0f66be98 |
| PRODUCT NDC: | 62856-600 |
| APPLICATION NUMBER: | NDA021790 |
Other DECITABINE Pharmaceutical Manufacturers / Labelers:
